<DOC>
	<DOC>NCT01635270</DOC>
	<brief_summary>The purpose of this study is to establish on the market and to clinically evaluate a new strategy of treatment for patients with locally advanced non-small cell lung cancer using deformable repositioning of 4D imaging.</brief_summary>
	<brief_title>Phase 2 Study Evaluating Mid-position Strategy in Radiotherapy Treatment for Patients With a Locally Advanced Non-small Cell Lung Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<criteria>patient with a NSCLC, nonresected, nonmetastatic including a parenchyma portion Age &gt;= 18 years PS &lt;=2 CTscan within 3 months at inclusion PETscan within 3 months at inclusion Respiratory functional exploration within 3 months at inclusion estimated V20 (by radiotherapist)&lt; 35% on conventional preradiotherapy imaging Tumor T0 to T4, M0; N1, N2 ou N3 by isolateral supraclavicular involvement Measurable disease according to RECIST criteria 1.1 Curative intent Chest conventional radiation therapy Radiation indication validated by a multidisciplinary meeting Adequate contraceptive method for the whole study duration and for up to 28 days after the end of radiation Mandatory affiliation with a health insurance company Patients must provide dated &amp; written consent Prior surgery for NSCLC NSCLC nearby pulmonary apex or strictly intrathoracic with no intraparenchyma portion Metastatic disease or N3 contralateral lymph node History of chest irradiation History of known increased intrinsic radiosensibility Hypersensibility to active substance or excipient of fluorodeoxyglucose18F Life expectancy &lt; 6 months Patient with a concurrent malignancy or with a history of malignancy (excepted adequately treated basal cell skin carcinoma or cervical squamous cell carcinoma or other malignancies free of the disease for at least 5 years) Pregnant or breastfeeding women Psychological, sociological or geographical conditions that would limit compliance with study requirements Patient deprived of freedom Patient has concomitant participation to an other investigational study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>